FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090222 [Registered on: 04/07/2025] Trial Registered Prospectively
Last Modified On: 26/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Clinical correlations of kidney biopsies among patients with unexplained chronic kidney disease to aid better understanding of unexplained chronic kidney disease in the region 
Scientific Title of Study   Clinicopathologic correlation of kidney biopsies done in patients with unexplained chronic kidney disease – a prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Namrata Rao S 
Designation  Additional Professor, Department of Nephrology 
Affiliation  Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow 
Address  Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  09454360872  
Fax    
Email  snamratarao@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Vinay Pratap Singh 
Designation  Senior Resident, Department of Nephrology 
Affiliation  Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow 
Address  Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  9140070226  
Fax    
Email  vinayps589@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Namrata Rao S 
Designation  Additional Professor, Department of Nephrology 
Affiliation  Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow 
Address  Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  09454360872  
Fax    
Email  snamratarao@yahoo.co.in  
 
Source of Monetary or Material Support  
Dr Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow, India, PIN - 226010 
 
Primary Sponsor  
Name  Dr Namrata Rao S 
Address  Department of Nephrology, Dr Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Lucknow - 226010 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Namrata Rao S  Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow  OPD No. 39, Ground Floor, OPD Block, Department of Nephrology, Dr.Ram Manohar Lohia Institute of Medical Sciences, Vibhuti Khand, Gomti Nagar, Lucknow
Lucknow
UTTAR PRADESH 
09454360872

snamratarao@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N189||Chronic kidney disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  The diagnosis of unexplained chronic kidney disease will be made using:
1. Those with short duration of renal-specific symptoms and no baseline renal function tests available
2. Those with short duration of hypertension and no ophthalmoscopic findings of hypertensive retinopathy
3. Those with normal sized kidneys with/ without alterations of corticomedullary echotexture on ultrasound examination, but no urinary tract obstruction, stones, multiple cysts (defined as the presence of three or more (unilateral or bilateral) renal cysts in individuals aged 15 to 39 years, two or more cysts in each kidney is sufficient for individuals aged 40 to 59 years, and four or more cysts in each kidney is required for individuals more than 60 yr.)or single kidney
4. Those with non-nephrotic proteinuria with/without urinary sediment changes
5. Non-diabetic/ Diabetic without diabetic retinopathy
6. No previous kidney biopsy suggestive of another basic kidney disease

Screening inclusion criteria :Patients Decisioned for kidney biopsy for “unexplained renal failure”, per institutional protocol, by treating nephrologist (eGFR less than 60 ml/min/1.73m2) with/without urinary sediment abnormalities, who
1. are adults more than 18 years of age
2. giving informed consent for participation in study

Final inclusion criteria:
1. Availability of baseline eGFR 3 months or earlier less than 60 ml/min/1.73 m2 or
2. For study participants without baseline eGFR, follow-up for next 3 months with follow-up eGFR less than 60 ml/min/1.73 m2
 
 
ExclusionCriteria 
Details  Patients not fulfilling institutional criteria for “unexplained renal failure” (positive serologies, underlying diabetes mellitus with diabetic retinopathy, longstanding hypertension with more than two anti-hypertensive drug use and presence of hypertensive retinopathy, long-term use of NSAIDs, among others)

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To estimate the prevalence of chronic tubulointerstitial inflammation and/or fibrosis (CTIN) among renal biopsies performed in patients for unexplained renal failure having chronic kidney disease  To estimate the prevalence of chronic tubulointerstitial inflammation and/or fibrosis (CTIN) among renal biopsies performed in patients for unexplained renal failure having chronic kidney disease - of successive patients for study duration of 2 years 
 
Secondary Outcome  
Outcome  TimePoints 
To examine clinical characteristics that can predict chronic tubulointerstitial nephritis on renal biopsy   To examine clinical characteristics that can predict chronic tubulointerstitial nephritis on renal biopsy - of successive patients for study duration of 2 years 
To compare the serum levels of heavy metals between groups of patients with chronic kidney disease designated as chronic tubulointerstitial nephritis, chronic glomerulonephritis and combined findings (chronic tubulointerstitial nephritis and glomerulosclerosis)  To compare the serum levels of heavy metals between groups of patients with chronic kidney disease designated as chronic tubulointerstitial nephritis, chronic glomerulonephritis and combined findings (chronic tubulointerstitial nephritis and glomerulosclerosis) - of successive patients for study duration of 2 years 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response - None of the above

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [snamratarao@yahoo.co.in].

  6. For how long will this data be available start date provided 02-11-2027 and end date provided 02-11-2032?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

CKDu has been described in endemic hotspots globally for the last few decades, appearing as chronic interstitial nephritis in predominantly agricultural communities in tropical climates such as India, Sri Lanka, and many South and Central American countries.The majority of reports of CKDu in India come from southern India, where the climate remains hot and humid through the year; however, CKDu hotspots have been described in Kanpur from Uttar Pradesh, and in Chattisgarh and Punjab too, where temperature and relative humidity dip significantly in the winter months. Whether these northern Indian hotspots correspond to CKDu or not, is presently unclear. 

The histopathologic characteristics in CKDu are predominantly those of chronic tubulointerstitial nephritis, albeit with a host of other biopsy findings (glomerulosclerosis, interstitial fibrosis, microvascular changes) described in biopsies done from identified hotspots of CKDu. These histologic features may vary between various agricultural communities from different parts of the world. Characterizing these histopathologic features, correlating the same with the history of exposure to agrochemicals, heat stress and other putative CKDu causative factors, and also measuring blood and urine levels of these heavy metals and agrochemicals, will prove to be an essential step in further research work into CKDu in this region. In the last two decades, various epidemiologic and environmental studies have elucidated on the role of exposure to pesticides in the development of CKD. These studies have been performed, both in patients affected by CKD as well as in population-based studies in farming communities. Pesticides such as organophosphate and glyphosate have been linked to the development of CKDu in Sri Lanka, to a certain extent. However, the lack of uniformity of findings across studies in the MesoAmerican region, and the lack of similar studies in India, make it difficult to attribute the disease to these causes alone.

Assessment

On the day of the biopsy, 5 ml of blood and be drawn from patients of “unexplained renal failure” undergoing biopsy with informed consent.

 

Pathological Assessments:

 Renal biopsy sample would be analysed under light microscopy and Immunofluoroscence (IF) study and reported by Nephropathologist at Dr. RMLIMS, Lucknow

Findings on the biopsy are noted – including percentage of sclerosed glomeruli, percentage of tubular atrophy, percentage of interstitial fibrosis, percentage of TI inflammation, whether glomerular immune deposits are seen or not on IF (+/- endocapillary/mesangial hypercellularity). They will be divided into following groups

 

1.CTIN- Purely chronic tubulointerstitial inflammation/ fibrosis OR Chronic tubulointerstitial inflammation more intense than glomerulosclerosis (viable glomeruli unremarkable) and negative IF

2. DGGS + CTIN (negative IF)- Equal intensity of chronic tubulointerstitial inflammation/ fibrosis and glomeruloslerosis (viable glomeruli unremarkable) and negative IF

3. CGN: More intense glomerulosclerosis (viable glomeruli showing abnormalities other than periglomerular fibrosis) than chronic tubulointerstitial inflammation/ fibrosis. Negative/ positive IF

Biochemical Assessments: Estimation of heavy metals in serum (Cadmium, Lead, Aluminum, Copper, Mercury, Calcium, Iron, Sodium, and Zinc)

The clinical and biochemical details will be noted from the file and hospital information system, after taking informed consent from the patients

Statistical analysis (relevant to thesis)

Data analysis will be done by using SPSS version 16 (IBM Inc., WA, USA). A p-value of < 0.05 will be considered statistically significant

Comparisons between CTIN, DGGS + CTIN (Negative IF) and CGN groups in terms of clinical, biochemical characteristics and parameters as per questionnaire  would be done.

Continuous variables would be assessed using unpaired t-test, while categorical variables would be assessed using Pearson chi-square test.

Logistic regression will be performed to look for risk factors for CTIN on renal biopsies.

 
Close